Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir vs Efavirenz with Epzicom in HIV
NCT00280969Phase 3Completed
- Sponsor
- National Center for Global Health and Medicine
- Start
- Sep 2005
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by National Center for Global Health and Medicine. Started Sep 2005; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00280969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280969.